Glutathione S-Transferase P1 ILE105Val Polymorphism in Occupationally Exposed Bladder Cancer Cases

By Kopps Silke   Angeli-Greaves Miriam   Blaszkewicz Meinolf   Prager Hans-Martin   Roemer Hermann   Lohlein Dietrich   Weistenhofer Wobbeke   Bolt Hermann   Golka Klaus  

Journal of Toxicology and Environmental Health, Vol. 71, Iss. 13-14, 2008-01 ,pp. : 898-901

Taylor & Francis Ltd

Access to resources Recommend Favorite

Determination of ERCC2 Lys751Gln and GSTP1 Ile105Val gene polymorphisms in colorectal cancer patients: relationships with treatment outcome

By Le Morvan Valéérie   Smith Denis   Laurand Armelle   Brouste Vééronique   Bellott Ricardo   Soubeyran Isabelle   Mathoulin-Pelissier Simone   Robert Jacques  

Pharmacogenomics, Vol. 8, Iss. 12, 2007-12 ,pp. : 1693-1703

Future Medicine

Access to resources Recommend Favorite

Change in Cycle 1 to Cycle 2 Haematological Counts Predicts Toxicity in Older Patients with Breast Cancer Receiving Adjuvant Chemotherapy

By Hurria Arti   Brogan Kelly   Panageas Katherine S.   Jakubowski Ann   Zauderer Marjorie   Pearce Carol   Norton Larry   Howard Jane   Hudis Clifford  

Drugs & Aging, Vol. 22, Iss. 8, 2005-01 ,pp. : 709-715

Adis International

Access to resources Recommend Favorite

Utilization of glutathione S-transferase Mu 1 - and Theta 1 -null mice as animal models for absorption, distribution, metabolism, excretion and toxicity studies

By Arakawa Shingo  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 6, 2013-06 ,pp. : 725-736

Informa Healthcare

Access to resources Recommend Favorite

Glutathione S-transferase (GST) inhibitors

By Mathew Nisha   Kalyanasundaram Muthuswami   Balaraman Kothandapani  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 4, 2006-04 ,pp. : 431-444

Informa Healthcare

Access to resources Recommend Favorite